NO20032111L - New drug mixtures based on tiotropium salts and on salmeterol salts - Google Patents
New drug mixtures based on tiotropium salts and on salmeterol saltsInfo
- Publication number
- NO20032111L NO20032111L NO20032111A NO20032111A NO20032111L NO 20032111 L NO20032111 L NO 20032111L NO 20032111 A NO20032111 A NO 20032111A NO 20032111 A NO20032111 A NO 20032111A NO 20032111 L NO20032111 L NO 20032111L
- Authority
- NO
- Norway
- Prior art keywords
- salts
- salmeterol
- new drug
- tiotropium
- mixtures based
- Prior art date
Links
- GIIZNNXWQWCKIB-UHFFFAOYSA-N Serevent Chemical class C1=C(O)C(CO)=CC(C(O)CNCCCCCCOCCCCC=2C=CC=CC=2)=C1 GIIZNNXWQWCKIB-UHFFFAOYSA-N 0.000 title abstract 2
- 239000000203 mixture Substances 0.000 title abstract 2
- LERNTVKEWCAPOY-DZZGSBJMSA-N tiotropium Chemical class O([C@H]1C[C@@H]2[N+]([C@H](C1)[C@@H]1[C@H]2O1)(C)C)C(=O)C(O)(C=1SC=CC=1)C1=CC=CS1 LERNTVKEWCAPOY-DZZGSBJMSA-N 0.000 title abstract 2
- 239000002547 new drug Substances 0.000 title 1
- 229940079593 drug Drugs 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 208000023504 respiratory system disease Diseases 0.000 abstract 1
- 238000002560 therapeutic procedure Methods 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/46—8-Azabicyclo [3.2.1] octane; Derivatives thereof, e.g. atropine, cocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/007—Pulmonary tract; Aromatherapy
- A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
- A61K9/0078—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a nebulizer such as a jet nebulizer, ultrasonic nebulizer, e.g. in the form of aqueous drug solutions or dispersions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
- A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/439—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom the ring forming part of a bridged ring system, e.g. quinuclidine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/007—Pulmonary tract; Aromatherapy
- A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
- A61K9/0075—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a dry powder inhaler [DPI], e.g. comprising micronized drug mixed with lactose carrier particles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/007—Pulmonary tract; Aromatherapy
- A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
- A61K9/008—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy comprising drug dissolved or suspended in liquid propellant for inhalation via a pressurized metered dose inhaler [MDI]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pulmonology (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Otolaryngology (AREA)
- Emergency Medicine (AREA)
- Dispersion Chemistry (AREA)
- Immunology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Abstract
Den foreliggende oppfinnelse vedrører nye legemiddelblandinger på basis av Tiotropiumsalter og salter av Salmeterol, en fremgangsmåte for deres fremstilling samt deres anvendelse ved terapi av luftveissykdommer.The present invention relates to novel drug compositions based on Tiotropium salts and Salmeterol salts, to a process for their preparation and to their use in the therapy of respiratory diseases.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE10056104A DE10056104A1 (en) | 2000-11-13 | 2000-11-13 | Drug compositions useful for treatment of respiratory diseases, especially asthma and chronic obstructive pulmonary disease comprises tiotropium salts and salmeterol salts |
| PCT/EP2001/012962 WO2002038154A1 (en) | 2000-11-13 | 2001-11-09 | Novel medicament compositions based on tiotropium salts and on salmeterol salts |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| NO20032111D0 NO20032111D0 (en) | 2003-05-12 |
| NO20032111L true NO20032111L (en) | 2003-07-08 |
Family
ID=7663071
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO20032111A NO20032111L (en) | 2000-11-13 | 2003-05-12 | New drug mixtures based on tiotropium salts and on salmeterol salts |
Country Status (32)
| Country | Link |
|---|---|
| EP (3) | EP1335728B1 (en) |
| JP (2) | JP4282322B2 (en) |
| KR (2) | KR100940752B1 (en) |
| CN (1) | CN1678318A (en) |
| AT (2) | ATE291428T1 (en) |
| AU (3) | AU2002227910B2 (en) |
| BG (1) | BG107781A (en) |
| BR (1) | BR0115226A (en) |
| CA (1) | CA2429012A1 (en) |
| CY (1) | CY1106774T1 (en) |
| CZ (1) | CZ20031444A3 (en) |
| DE (3) | DE10056104A1 (en) |
| DK (2) | DK1335728T3 (en) |
| EA (1) | EA007904B1 (en) |
| EC (1) | ECSP034571A (en) |
| EE (1) | EE200300228A (en) |
| ES (2) | ES2287629T3 (en) |
| HR (1) | HRP20030378A2 (en) |
| HU (1) | HUP0301447A3 (en) |
| IL (2) | IL155718A0 (en) |
| MX (1) | MXPA03004164A (en) |
| NO (1) | NO20032111L (en) |
| NZ (1) | NZ526400A (en) |
| PL (1) | PL205330B1 (en) |
| PT (2) | PT1335728E (en) |
| RS (2) | RS20090105A (en) |
| SG (1) | SG167657A1 (en) |
| SI (2) | SI1514546T1 (en) |
| SK (2) | SK286950B6 (en) |
| UA (1) | UA74853C2 (en) |
| WO (1) | WO2002038154A1 (en) |
| ZA (1) | ZA200302921B (en) |
Families Citing this family (33)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2165768B1 (en) | 1999-07-14 | 2003-04-01 | Almirall Prodesfarma Sa | NEW DERIVATIVES OF QUINUCLIDINE AND PHARMACEUTICAL COMPOSITIONS THAT CONTAIN THEM. |
| US7214687B2 (en) | 1999-07-14 | 2007-05-08 | Almirall Ag | Quinuclidine derivatives and medicinal compositions containing the same |
| ES2234694T3 (en) * | 1999-11-23 | 2005-07-01 | Glaxo Group Limited | PHARMACEUTICAL FORMULATIONS OF SALMETEROL. |
| MXPA04002401A (en) * | 2001-09-14 | 2004-05-31 | Boehringer Ingelheim Pharma | Novel medicaments for inhalation. |
| US7244415B2 (en) | 2002-03-28 | 2007-07-17 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | HFA suspension formulations of an anhydrate |
| DE10214263A1 (en) * | 2002-03-28 | 2003-10-16 | Boehringer Ingelheim Pharma | HFA suspension formulations containing an anticholinergic |
| US7311894B2 (en) | 2002-03-28 | 2007-12-25 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | HFA suspension formulations containing an anticholinergic |
| DE10256080A1 (en) * | 2002-11-29 | 2004-06-17 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Combination medicinal product for inhalation containing tiotropium |
| US7250426B2 (en) | 2002-11-29 | 2007-07-31 | Boehringer Ingelheim Pharma Gmbh & Co Kg | Tiotropium-containing pharmaceutical combination for inhalation |
| EP1575588A1 (en) * | 2002-12-16 | 2005-09-21 | Boehringer Ingelheim Pharma GmbH & Co.KG | Tiotropium containing hfc solution formulations |
| DE10351663A1 (en) * | 2002-12-20 | 2004-07-01 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Stable, accurately dosable inhalable powder medicament for treating asthma or chronic obstructive pulmonary disease, containing tiotropium, specific form of salmeterol xinafoate and auxiliary |
| DE10345065A1 (en) * | 2003-09-26 | 2005-04-14 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Aerosol formulation for inhalation containing an anticholinergic |
| CA2544348A1 (en) * | 2003-11-03 | 2005-05-12 | Boehringer Ingelheim International Gmbh | Method for producing tiotropium salts, tiotropium salts and pharmaceutical formulations, containing the same |
| PL2083007T3 (en) * | 2003-11-03 | 2013-09-30 | Boehringer Ingelheim Int | Tiotropium salts, method for creating same and medicinal formulations containing same |
| WO2005115465A1 (en) * | 2004-05-31 | 2005-12-08 | Almirall Prodesfarma S.A. | Combinations comprising antimuscarinic agents and pde4 inhibitors |
| ES2257152B1 (en) * | 2004-05-31 | 2007-07-01 | Laboratorios Almirall S.A. | COMBINATIONS THAT INCLUDE ANTIMUSCARINIC AGENTS AND BETA-ADRENERGIC AGONISTS. |
| NZ563596A (en) | 2005-05-02 | 2011-01-28 | Boehringer Ingelheim Int | Crystalline form of tiotropium bromide anhydrate |
| EP1959942A1 (en) * | 2005-08-06 | 2008-08-27 | Boehringer Ingelheim International GmbH | Method for the treatment of dyspnea comprising combined administration of tiotropium salts and salts of salmeterol |
| ES2298049B1 (en) | 2006-07-21 | 2009-10-20 | Laboratorios Almirall S.A. | PROCEDURE FOR MANUFACTURING BROMIDE OF 3 (R) - (2-HIDROXI-2,2-DITIEN-2-ILACETOXI) -1- (3-PHENOXIPROPIL) -1-AZONIABICICLO (2.2.2) OCTANO. |
| EP2100599A1 (en) | 2008-03-13 | 2009-09-16 | Laboratorios Almirall, S.A. | Inhalation composition containing aclidinium for treatment of asthma and chronic obstructive pulmonary disease |
| EP2100598A1 (en) | 2008-03-13 | 2009-09-16 | Laboratorios Almirall, S.A. | Inhalation composition containing aclidinium for treatment of asthma and chronic obstructive pulmonary disease |
| US20120220557A1 (en) * | 2011-02-17 | 2012-08-30 | Chiesi Farmaceutici S.P.A. | Liquid propellant-free formulation comprising an antimuscarinic drug |
| EP2510928A1 (en) | 2011-04-15 | 2012-10-17 | Almirall, S.A. | Aclidinium for use in improving the quality of sleep in respiratory patients |
| WO2013127738A1 (en) * | 2012-02-28 | 2013-09-06 | Boehringer Ingelheim International Gmbh | Novel propellant-gas-containing tiotropium formulation |
| WO2015065222A1 (en) * | 2013-10-28 | 2015-05-07 | Шолекс Девелопмент Гмбх | Pharmaceutical inhaled drug with micronized tiotropium bromide as active ingredient for the treatment of bronchial asthma and chronic obstructive pulmonary disease and method for producing same |
| TW201835041A (en) | 2017-02-17 | 2018-10-01 | 印度商托仁特生技有限公司 | Compounds with Beta-Adrenergic Agonist and Antimuscarinic Activity |
| WO2019142214A1 (en) * | 2018-01-19 | 2019-07-25 | Cipla Limited | Pharmaceutical composition comprising tiotropium for inhalation |
| CN116196298A (en) * | 2018-07-26 | 2023-06-02 | 四川海思科制药有限公司 | Aerosol pharmaceutical composition containing glycopyrronium salt and preparation method and application thereof |
| WO2020019952A1 (en) * | 2018-07-26 | 2020-01-30 | 四川海思科制药有限公司 | Aerosol pharmaceutical composition containing glycopyrrolate salt and indacaterol salt, preparation method therefor, and uses thereof |
| US12042514B2 (en) | 2020-05-01 | 2024-07-23 | Tygrus, LLC | Therapeutic material with low pH and low toxicity active against at least one pathogen for addressing patients with respiratory illnesses |
| US11642372B2 (en) | 2020-05-01 | 2023-05-09 | Tygrus, LLC | Therapeutic material with low pH and low toxicity active against at least one pathogen for addressing patients with respiratory illnesses |
| WO2022119661A1 (en) * | 2020-12-04 | 2022-06-09 | Tygrus, LLC | THERAPEUTIC MATERIAL WITH LOW pH AND LOW TOXICITY ACTIVE AGAINST AT LEAST ONE PATHOGEN FOR ADDRESSING PATIENTS WITH RESPIRATORY ILLNESSES |
| US11826382B2 (en) | 2020-05-01 | 2023-11-28 | Tygrus, LLC | Therapeutic material with low pH and low toxicity active against at least one pathogen for addressing patients with respiratory illnesses |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2234266T3 (en) * | 1998-07-24 | 2005-06-16 | Jago Research Ag | MEDICAL FORMULATIONS FOR AEROSOLS. |
| DE19835346A1 (en) * | 1998-08-05 | 2000-02-10 | Boehringer Ingelheim Pharma | Two-part capsule for pharmaceutical preparations for powder inhalers |
| DE19847970A1 (en) * | 1998-10-17 | 2000-04-20 | Boehringer Ingelheim Pharma | Stable concentrated liquid formulation of inhalable drug, e.g. formoterol or salbutamol, in solution or suspension medium, used after dilution for treatment of respiratory disorders by inhalation |
| DE19847971A1 (en) * | 1998-10-17 | 1999-09-02 | Schiering | Filter fire occurrence prevention method |
| DE19921693A1 (en) * | 1999-05-12 | 2000-11-16 | Boehringer Ingelheim Pharma | Pharmaceutical composition for treating respiratory disorders, e.g. asthma, comprises combination of anticholinergic and beta-mimetic agents having synergistic bronchospasmolytic activity and reduced side-effects |
| DE19961300A1 (en) * | 1999-12-18 | 2001-06-21 | Asta Medica Ag | Storage system for medicinal products in powder form and inhaler equipped with them |
-
2000
- 2000-11-13 DE DE10056104A patent/DE10056104A1/en not_active Withdrawn
-
2001
- 2001-09-11 UA UA2003065486A patent/UA74853C2/en unknown
- 2001-11-09 EP EP01989446A patent/EP1335728B1/en not_active Expired - Lifetime
- 2001-11-09 BR BR0115226-2A patent/BR0115226A/en active Pending
- 2001-11-09 AT AT01989446T patent/ATE291428T1/en active
- 2001-11-09 RS RSP-2009/0105A patent/RS20090105A/en unknown
- 2001-11-09 IL IL15571801A patent/IL155718A0/en unknown
- 2001-11-09 RS YUP-355/03A patent/RS50286B/en unknown
- 2001-11-09 SI SI200130751T patent/SI1514546T1/en unknown
- 2001-11-09 SI SI200130347T patent/SI1335728T1/en unknown
- 2001-11-09 EP EP04028508A patent/EP1514546B1/en not_active Expired - Lifetime
- 2001-11-09 AU AU2002227910A patent/AU2002227910B2/en not_active Ceased
- 2001-11-09 DE DE50105729T patent/DE50105729D1/en not_active Expired - Lifetime
- 2001-11-09 CN CNA018187773A patent/CN1678318A/en active Pending
- 2001-11-09 CZ CZ20031444A patent/CZ20031444A3/en unknown
- 2001-11-09 AU AU2791002A patent/AU2791002A/en active Pending
- 2001-11-09 EA EA200300503A patent/EA007904B1/en not_active IP Right Cessation
- 2001-11-09 SG SG200505149-5A patent/SG167657A1/en unknown
- 2001-11-09 EP EP07104722A patent/EP1808174A1/en not_active Withdrawn
- 2001-11-09 PL PL365989A patent/PL205330B1/en not_active IP Right Cessation
- 2001-11-09 PT PT01989446T patent/PT1335728E/en unknown
- 2001-11-09 EE EEP200300228A patent/EE200300228A/en unknown
- 2001-11-09 AT AT04028508T patent/ATE362761T1/en active
- 2001-11-09 DK DK01989446T patent/DK1335728T3/en active
- 2001-11-09 ES ES04028508T patent/ES2287629T3/en not_active Expired - Lifetime
- 2001-11-09 MX MXPA03004164A patent/MXPA03004164A/en active IP Right Grant
- 2001-11-09 CA CA002429012A patent/CA2429012A1/en not_active Abandoned
- 2001-11-09 HU HU0301447A patent/HUP0301447A3/en unknown
- 2001-11-09 KR KR1020087020177A patent/KR100940752B1/en not_active IP Right Cessation
- 2001-11-09 JP JP2002540737A patent/JP4282322B2/en not_active Expired - Lifetime
- 2001-11-09 KR KR1020037006434A patent/KR100886094B1/en not_active IP Right Cessation
- 2001-11-09 SK SK50015-2009A patent/SK286950B6/en not_active IP Right Cessation
- 2001-11-09 NZ NZ526400A patent/NZ526400A/en unknown
- 2001-11-09 DK DK04028508T patent/DK1514546T3/en active
- 2001-11-09 PT PT04028508T patent/PT1514546E/en unknown
- 2001-11-09 SK SK741-2003A patent/SK286939B6/en not_active IP Right Cessation
- 2001-11-09 WO PCT/EP2001/012962 patent/WO2002038154A1/en active Application Filing
- 2001-11-09 DE DE50112535T patent/DE50112535D1/en not_active Expired - Lifetime
- 2001-11-09 ES ES01989446T patent/ES2240549T3/en not_active Expired - Lifetime
-
2003
- 2003-04-14 ZA ZA200302921A patent/ZA200302921B/en unknown
- 2003-04-28 EC EC2003004571A patent/ECSP034571A/en unknown
- 2003-05-01 IL IL155718A patent/IL155718A/en not_active IP Right Cessation
- 2003-05-08 BG BG107781A patent/BG107781A/en active Pending
- 2003-05-12 NO NO20032111A patent/NO20032111L/en not_active Application Discontinuation
- 2003-05-12 HR HR20030378A patent/HRP20030378A2/en not_active Application Discontinuation
-
2004
- 2004-12-08 JP JP2004355226A patent/JP4282594B2/en not_active Expired - Lifetime
-
2007
- 2007-05-22 AU AU2007202303A patent/AU2007202303B2/en not_active Ceased
- 2007-07-30 CY CY20071101011T patent/CY1106774T1/en unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO20032111L (en) | New drug mixtures based on tiotropium salts and on salmeterol salts | |
| NO20093464L (en) | New drug mixtures based on anti-cholinergically effective compounds and beta-mimetics | |
| EE200400020A (en) | Substituted oxazolidinones for combination therapy | |
| MXPA03011515A (en) | Novel pharmaceutical compositions based on anticholinergic agents, corticosteroids and betamimetic agents. | |
| UA85708C2 (en) | Benzoxazine-containing pharmaceutical combinations for treating respiratory tract diseases | |
| SE0104341D0 (en) | New use | |
| BR0309185A (en) | Beta-mimetic drug and a new anticholinergic | |
| UA90504C2 (en) | Novel drugs for treating respiratory diseases | |
| EA200600854A1 (en) | NEW TIOTROPY SALTS, METHOD OF THEIR PRODUCTION, AND ALSO CONTAINING THEIR MEDICINAL COMPOSITIONS | |
| HUP0204520A2 (en) | Pharmaceutical composition containing esmolol and process for its preparation | |
| NO20054767L (en) | Compositions comprising apomorphine for lung inhalation | |
| TW200612922A (en) | Inhibitors of hsp90 | |
| RS20060292A (en) | Method for producing tiotropium salts, tiotropium salts and pharmaceutical formulations, containing the same | |
| MEP54208A (en) | Medicaments containing steroids and a novel anticholinesterase drug | |
| ATE452639T1 (en) | MEDICINAL COMPOSITIONS OF TIOTROPIUM SALTS AND EPINASTINE FOR THE THERAPY OF RESPIRATORY DISEASES | |
| BR0307703A (en) | Drug compositions based on anticholinergic agents and egfr kinase inhibitors | |
| BRPI0413054A (en) | combination of an anticholinergic and a steroid and its use in the treatment of inhalation breathing disorders | |
| MXPA04002401A (en) | Novel medicaments for inhalation. | |
| MXPA03008406A (en) | Novel medicament compositions based on anticholinergic agents and endothelin antagonists. | |
| DK1581224T3 (en) | Tiotropium-containing drug composition for inhalation | |
| MXPA03005585A (en) | Novel pharmaceutical compositions based on anticholinergic agents and dopamine agonists. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC2A | Withdrawal, rejection or dismissal of laid open patent application |